Cutler Group LP Oramed Pharmaceuticals Inc. Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 07, 2023	SELL	$6.21 - $12.03 $621 - $1,203	-100 Reduced 25.0%	300 $2,000
Q3 2022 Oct 25, 2022	SELL	$4.6 - $9.91 $11,959 - $25,766	-2,600 Reduced 86.67%	400 $1,000
Q2 2022 Aug 04, 2022	SELL	$3.72 - $9.0 $14,880 - $36,000	-4,000 Reduced 57.14%	3,000 $0
Q1 2022 Apr 14, 2022	SELL	$8.19 - $13.89 $234,234 - $397,254	-28,600 Reduced 80.34%	7,000 $2,000
Q4 2021 Jan 18, 2022	BUY	$12.98 - $29.75 $324,500 - $743,750	25,000 Added 235.85%	35,600 $20,000

Q3 2021 Oct 26, 2021	BUY	$12.13 - $23.82 $128,578 - $252,492	10,600 New	10,600 $58,000

5.69M

8.3K

2.7K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $97.8M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.